Article information
Full text is only aviable in PDF
References
[1.]
G. Varela, J.A. Barberà, R. Cordovilla, J.L. Duque-Medina, A. López-Encuentra, L. Puente-Maestu.
Normativa sobre valoración del riesgo quirúrgico en el carcinoma broncogénico.
Arch Bronconeumol, 41 (2005), pp. 686-697
[2.]
A. Brunelli, A. Charloux, C.T. Bolliger, G. Rocco, J.P. Sculier, G. Varela, et al.
European Respiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).
Eur Respir J, 34 (2009), pp. 17-41
[3.]
G.L. Colice, S. Shafazand, J.P. Griffin, R. Keenan, C.T. Bolliger.
American College of Chest Physicians Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).
Chest, 132 (2007), pp. 161-177
[4.]
The ESTS Datbase Committee. Database Annual Report 2009 [consultado 3/8/2009]. Disponible en: http://abrunelli.bravehost.com/Silver%20book%20final%20draft.pdf
[5.]
R. Rami-Porta, J.J. Crowley, P. Goldstraw.
The revised TNM staging system for lung cancer.
Ann Thorac Cardiovasc Surg, 15 (2009), pp. 4-9
[6.]
K.S. Albain, R.S. Swann, V.W. Rusch, A.T. Turrisi III, F.A. Shepherd, C. Smith, et al.
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.
Lancet, 374 (2009), pp. 379-386
[7.]
J.P. Van Meerbeeck, G.W. Kramer, P.E. Van Schil, C. Legrand, E.F. Smit, F. Schramel, et al.
European Organisation for Research and Treatment of Cancer-Lung Cancer Group. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
J Natl Cancer Inst, 99 (2007), pp. 442-450
[8.]
A. Brunelli, M.A. Refai, M. Salati, A. Sabbatini, N.J. Morgan-Hughes, G. Rocco.
Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection.
Eur J Cardiothorac Surg, 29 (2006), pp. 567-570
[9.]
F. Leo, G. Pelosi, A. Sonzogni, M. Chilosi, G. Bonomo, L. Spaggiari.
Structural lung damage after chemotherapy Fact or fiction?.
Lung Cancer, (2009),
[10.]
G. Varela, A. Brunelli, G. Rocco, M.F. Jiménez, M. Salati, T. Gatani.
Evidence of lower alteration of expiratory volume in patients with airflow limitation in the immediate period after lobectomy.
Ann Thorac Surg, 84 (2007), pp. 417-422
[11.]
K. Kashiwabara, J.I. Sasaki, T. Mori, H. Nomori, K. Fujii, H. Kohrogi.
Relationship between functional preservation after segmentectomy and volume-reduction effects after lobectomy in stage I non-small cell lung cancer patients with emphysema.
J Thorac Oncol, 4 (2009), pp. 1111-1116
[12.]
G. Varela, L. Molins, J. Astudillo, J.M. Borro, E. Canalís, J. Freixinet, et al.
Experiencia piloto de benchmarking en cirugía torácica: comparación de la casuística e indicadores de calidad en resección pulmonar.
Arch Bronconeumol, 42 (2006), pp. 267-272
[13.]
A. Brunelli, G. Varela, P. Van Schil, M. Salati, N. Novoa, J.M. Hendriks, on behalf of the ESTS Audit and Clinical Excellence Committee, et al.
Multicentric analysis of performance after major lung resections by using the European Society Objective Score (ESOS).
Eur J Cardiothorac Surg, 33 (2008), pp. 282-288
Copyright © 2009. Sociedad Española de Neumología y Cirugía Torácica
